Vivierskin Sunscreen SPF 30

Dosage form: lotion
Ingredients: AVOBENZONE 2.5mL in 100mL, OCTINOXATE 5.5mL in 100mL, ENSULIZOLE 2.0mL in 100mL
Labeler: Vivier Pharma, Inc.
NDC Code: 67226-2030

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

Vivierskin Sunscreen Lotion SPF 30

Active Ingredients

2.5% Avobenzone

5.5% Octinoxate

2.0% Phenylbenzimidazole-5-Sulfonic Acid

Purpose

Sunscreen

Uses• Helps prevent sunburn
• Provides broad-spectrum UVA/UVB protection
• Ideal for daily use; can be applied under makeup
• Optimal for post-care or on sensitive skin

Warnings

For external use only

When using this product

Keep out of eyes. Rinse with water to remove

Stop use and ask a doctor if

rash or irritation develops and lasts

Keep out of reach of children

■ If swallowed, get medical help or contact a Poison Control Center right away

Directions

■ Apply daily to face, neck and chest.

■ Apply liberally 15–30 minutes before sun exposure and as needed.

■ Reapply after towel drying, swimming or sweating.

■ For children under six months of age, consult a physician.

Inactive Ingredients

Butylated Hydroxytoluene, Carbomer, Cetyl Alcohol, DEA-Cetyl Phosphate, Dexpanthenol, Dimethicone, Disodium Edetate, 4-Methylbenzilidene Camphor, Octyldodecyl Neopentanoate, Phenoxyethanol and Methyl paraben and Ethylparaben and Propylparaben and Butylparaben, Propylene Glycol, Sodium hydroxide, Stearic Acid, Triethanolamine, Vitamin E, Water/Eau.

Questions or Comments

450 455 9779                           1 877 484 8437

Store at room temperature (15-30°C / 59-86°F).


SUNSCREEN
LOTION
SPF 30
ENRICHED WITH
ANTIOXIDANTS


Dist. by Vivier Pharma
Champlain NY USA 12919
vivierpharma.com

® Vivier Canada Inc.
– used under license



Made in Canada

VIVIERSKIN SUNSCREEN  SPF 30
avobenzone, octinoxate, ensulizole lotion
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:67226-2030
Route of AdministrationTOPICALDEA Schedule    
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
AVOBENZONE (AVOBENZONE) AVOBENZONE2.5 mL  in 100 mL
OCTINOXATE (OCTINOXATE) OCTINOXATE5.5 mL  in 100 mL
ENSULIZOLE (ENSULIZOLE) ENSULIZOLE2.0 mL  in 100 mL
Inactive Ingredients
Ingredient NameStrength
WATER 
OCTYLDODECYL NEOPENTANOATE 
PROPYLENE GLYCOL 
STEARIC ACID 
ALPHA-TOCOPHEROL 
DIETHANOLAMINE CETYL PHOSPHATE 
CETYL ALCOHOL 
PANTOTHENIC ACID 
PHENOXYETHANOL 
BUTYLPARABEN 
ETHYLPARABEN 
METHYLPARABEN 
PROPYLPARABEN 
DIMETHICONE 
SODIUM HYDROXIDE 
BUTYLATED HYDROXYTOLUENE 
EDETATE DISODIUM 
TROLAMINE 
Packaging
#Item CodePackage Description
1NDC:67226-2030-61 BOTTLE (BOTTLE) in 1 BOX
160 mL in 1 BOTTLE
2NDC:67226-2030-11 BOTTLE (BOTTLE) in 1 BOX
2100 mL in 1 BOTTLE
3NDC:67226-2030-5500 mL in 1 BOTTLE
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph not finalpart35203/23/2011
Labeler - Vivier Pharma, Inc. (250996550)

Revised: 04/2011
 
Vivier Pharma, Inc.

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.

Hide
(web5)